IL164442A0 - Benzoxazinone-derived compounds, their preparationand use as medicaments - Google Patents

Benzoxazinone-derived compounds, their preparationand use as medicaments

Info

Publication number: IL164442A0
Authority: IL; Israel
Prior art keywords: preparationand; benzoxazinone; medicaments; derived compounds; derived
Prior art date: 2002-04-09

Application number

IL16444203A

Other languages

English (en)

Original Assignee

Esteve Labor Dr

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-09

Filing date

2003-04-08

Publication date

2005-12-18

2003-04-08 Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr

2005-12-18 Publication of IL164442A0 publication Critical patent/IL164442A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

IL16444203A 2002-04-09 2003-04-08 Benzoxazinone-derived compounds, their preparationand use as medicaments IL164442A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200200813A ES2193875B2 (es)	2002-04-09	2002-04-09	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
PCT/EP2003/003629 WO2003084952A1 (en)	2002-04-09	2003-04-08	Benzoxazinone-derived compounds, their preparation und use as medicaments

Publications (1)

Publication Number	Publication Date
IL164442A0 true IL164442A0 (en)	2005-12-18

Family

ID=28686085

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16444203A IL164442A0 (en)	2002-04-09	2003-04-08	Benzoxazinone-derived compounds, their preparationand use as medicaments

Country Status (29)

Country	Link
US (3)	US7056914B2 (xx)
EP (2)	EP1497285B1 (xx)
JP (1)	JP2005529866A (xx)
KR (1)	KR20050008679A (xx)
CN (1)	CN1659164A (xx)
AR (2)	AR039256A1 (xx)
AT (2)	ATE489382T1 (xx)
AU (2)	AU2003222804A1 (xx)
BR (1)	BR0309083A (xx)
CA (1)	CA2481701A1 (xx)
DE (2)	DE60335094D1 (xx)
DK (1)	DK1500654T3 (xx)
EC (1)	ECSP045353A (xx)
ES (3)	ES2193875B2 (xx)
HK (1)	HK1069820A1 (xx)
HR (1)	HRP20040919A2 (xx)
IL (1)	IL164442A0 (xx)
IS (1)	IS7491A (xx)
MA (1)	MA27692A1 (xx)
MX (1)	MXPA04009889A (xx)
NO (1)	NO20044322L (xx)
NZ (1)	NZ536167A (xx)
PL (1)	PL372537A1 (xx)
PT (1)	PT1500654E (xx)
RU (1)	RU2004133041A (xx)
TN (1)	TNSN04203A1 (xx)
UA (1)	UA79460C2 (xx)
WO (2)	WO2003084952A1 (xx)
ZA (1)	ZA200408275B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2193875B2 (es) *	2002-04-09	2005-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
ES2222833B1 (es) *	2003-07-30	2006-03-01	Laboratorios Del Dr. Esteve, S.A.	Compuestos piperidinicos 1,4-disustituidos, su preparacion y su uso como medicamentos.
ES2228268B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2228267B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
WO2005090340A1 (ja) *	2004-03-22	2005-09-29	Banyu Pharmaceutical Co., Ltd.	ピペリジン－１－カルボキサミド誘導体
US8147853B2 (en)	2005-02-15	2012-04-03	The Procter & Gamble Company	Personal care compositions containing hydrophobically modified non-platelet particles
WO2006102113A2 (en) *	2005-03-21	2006-09-28	The Procter & Gamble Company	Multi-phase personal care composition comprising visually distinct phases
WO2006113118A1 (en) *	2005-04-13	2006-10-26	The Procter & Gamble Company	Structured multi-phased personal care composition comprising branched anionic surfactants
US7820609B2 (en)	2005-04-13	2010-10-26	The Procter & Gamble Company	Mild, structured, multi-phase personal cleansing compositions comprising density modifiers
ITMI20050909A1 (it) *	2005-05-19	2006-11-20	Acraf	Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-
US20120015009A9 (en) *	2005-06-07	2012-01-19	The Procter & Gamble Company	Multi-phased personal care composition comprising a blooming perfume composition
ITMI20051523A1 (it) *	2005-08-03	2007-02-04	Acraf	Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
CN101326106A (zh) *	2005-12-08	2008-12-17	宝洁公司	包括邻近表面形貌定位的模内标签的容器
US20070167338A1 (en) *	2006-01-09	2007-07-19	Mchugh Colin M	Multiphase personal care compositions comprising beads
US8104616B2 (en)	2006-02-11	2012-01-31	The Procter & Gamble Company	Clamshell package for holding and displaying consumer products
US8153144B2 (en) *	2006-02-28	2012-04-10	The Proctor & Gamble Company	Stable multiphase composition comprising alkylamphoacetate
EP2061795B1 (en) *	2006-08-14	2014-01-15	Council of Scientific & Industrial Research	Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof
EP1902733A1 (en) *	2006-09-19	2008-03-26	Laboratorios Del Dr. Esteve, S.A.	Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity
CL2007003044A1 (es) *	2006-10-24	2008-07-04	Wyeth Corp	Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros.
US20090029900A1 (en) *	2007-07-27	2009-01-29	The Procter & Gamble Company	Personal care article for sequentially dispensing compositions with distinct fragrance characters
US20090028809A1 (en) *	2007-07-27	2009-01-29	Jonathan Robert Cetti	Personal care article for sequentially dispensing compositions with variable concentrations of hydrophobic benefit materials
US20090028808A1 (en) *	2007-07-27	2009-01-29	The Procter & Gamble Company	Personal care article for sequentially dispensing compositions with variable concentrations of partitioned benefit or suspended benefit agents
US7733945B2 (en) *	2008-03-18	2010-06-08	On-Ramp Wireless, Inc.	Spread spectrum with doppler optimization
US20090275574A1 (en) *	2008-05-05	2009-11-05	Astrazeneca Ab	Novel compounds-300
EP2404902A1 (en)	2009-03-05	2012-01-11	Shionogi&Co., Ltd.	Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
CN110684043B (zh) *	2019-08-13	2022-09-06	温州大学	一种c-n轴手性芳胺化合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09500134A (ja) *	1993-07-16	1997-01-07	メルクエンドカンパニーインコーポレーテッド	ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤
US5760054A (en)	1994-04-14	1998-06-02	Merck & Co., Inc.	Alpha IC adrenergic receptor antagonists
WO1997020823A2 (en)	1995-12-01	1997-06-12	Novartis Ag	2-amino quinazoline derivatives as npy receptor antagonists
AU1328197A (en)	1995-12-01	1997-06-19	Synaptic Pharmaceutical Corporation	Aryl sulfonamide and sulfamide derivatives and uses thereof
AU1698997A (en)	1996-01-16	1997-08-11	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
EP0944388A4 (en)	1996-04-03	2001-08-16	Merck & Co Inc	INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
AU5135998A (en)	1996-12-03	1998-06-29	Banyu Pharmaceutical Co., Ltd.	Novel urea derivatives
CA2251368A1 (en)	1997-02-14	1998-08-20	Bayer Corporation	Amide derivatives as selective neuropeptide y receptor antagonists
WO1998040356A1 (fr)	1997-03-12	1998-09-17	Banyu Pharmaceutical Co., Ltd.	Medicaments contenant des derives d'aminopyridine comme ingredient actif
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
BR9914360A (pt)	1998-10-07	2001-11-20	Ortho Mcneil Pharm Inc	N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
WO2001007409A1 (en)	1999-07-23	2001-02-01	Astrazeneca Uk Limited	Carbazole derivatives and their use as neuropeptide y5 receptor ligands
EP1206262A4 (en)	1999-08-26	2003-01-02	Bristol Myers Squibb Co	Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES
SE9904652D0 (sv) *	1999-12-17	1999-12-17	Astra Pharma Prod	Novel Compounds
AU2001246494A1 (en)	2000-03-03	2001-09-12	Novartis Ag	Condensed thiazolamines and their use as neuropeptide y5 antagonists
WO2002094825A1 (fr)	2001-05-22	2002-11-28	Banyu Pharmaceutical Co., Ltd.	Nouveau derive de spiropiperidine
WO2003014083A1 (fr) *	2001-08-07	2003-02-20	Banyu Pharmaceutical Co., Ltd.	Composes spiro
ES2193875B2 (es) *	2002-04-09	2005-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.

2002
- 2002-04-09 ES ES200200813A patent/ES2193875B2/es not_active Expired - Fee Related
2003
- 2003-04-04 US US10/407,343 patent/US7056914B2/en not_active Expired - Fee Related
- 2003-04-04 AR ARP030101184A patent/AR039256A1/es not_active Application Discontinuation
- 2003-04-08 RU RU2004133041/04A patent/RU2004133041A/ru not_active Application Discontinuation
- 2003-04-08 JP JP2003582149A patent/JP2005529866A/ja active Pending
- 2003-04-08 BR BR0309083-3A patent/BR0309083A/pt not_active IP Right Cessation
- 2003-04-08 NZ NZ536167A patent/NZ536167A/en unknown
- 2003-04-08 AT AT03718741T patent/ATE489382T1/de not_active IP Right Cessation
- 2003-04-08 AR ARP030101235A patent/AR048567A1/es not_active Application Discontinuation
- 2003-04-08 CA CA002481701A patent/CA2481701A1/en not_active Abandoned
- 2003-04-08 DE DE60335094T patent/DE60335094D1/de not_active Expired - Lifetime
- 2003-04-08 WO PCT/EP2003/003629 patent/WO2003084952A1/en active Application Filing
- 2003-04-08 PL PL03372537A patent/PL372537A1/xx not_active Application Discontinuation
- 2003-04-08 EP EP03718741A patent/EP1497285B1/en not_active Expired - Lifetime
- 2003-04-08 MX MXPA04009889A patent/MXPA04009889A/es active IP Right Grant
- 2003-04-08 ES ES03718741T patent/ES2356815T3/es not_active Expired - Lifetime
- 2003-04-08 KR KR10-2004-7016130A patent/KR20050008679A/ko not_active Application Discontinuation
- 2003-04-08 AU AU2003222804A patent/AU2003222804A1/en not_active Abandoned
- 2003-04-08 IL IL16444203A patent/IL164442A0/xx unknown
- 2003-04-08 US US10/409,235 patent/US7041665B2/en not_active Expired - Fee Related
- 2003-04-08 CN CN038128853A patent/CN1659164A/zh active Pending
- 2003-04-09 PT PT03712152T patent/PT1500654E/pt unknown
- 2003-04-09 ES ES03712152T patent/ES2258219T3/es not_active Expired - Lifetime
- 2003-04-09 DE DE60303440T patent/DE60303440T2/de not_active Expired - Lifetime
- 2003-04-09 EP EP03712152A patent/EP1500654B1/en not_active Expired - Lifetime
- 2003-04-09 AU AU2003216934A patent/AU2003216934A1/en not_active Abandoned
- 2003-04-09 WO PCT/ES2003/000162 patent/WO2003084939A1/es not_active Application Discontinuation
- 2003-04-09 AT AT03712152T patent/ATE316966T1/de not_active IP Right Cessation
- 2003-04-09 DK DK03712152T patent/DK1500654T3/da active
- 2003-08-04 UA UA20041109155A patent/UA79460C2/uk unknown
2004
- 2004-10-05 HR HR20040919A patent/HRP20040919A2/hr not_active Application Discontinuation
- 2004-10-06 IS IS7491A patent/IS7491A/is unknown
- 2004-10-08 TN TNP2004000203A patent/TNSN04203A1/en unknown
- 2004-10-08 EC EC2004005353A patent/ECSP045353A/es unknown
- 2004-10-08 MA MA27902A patent/MA27692A1/fr unknown
- 2004-10-12 NO NO20044322A patent/NO20044322L/no not_active Application Discontinuation
- 2004-10-13 ZA ZA200408275A patent/ZA200408275B/en unknown
2005
- 2005-03-09 HK HK05102067.9A patent/HK1069820A1/xx not_active IP Right Cessation
2006
- 2006-01-24 US US11/338,363 patent/US7514429B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7041665B2 (en)	2006-05-09
ES2193875B2 (es)	2005-03-01
PL372537A1 (en)	2005-07-25
EP1497285B1 (en)	2010-11-24
NO20044322L (no)	2004-10-12
MA27692A1 (fr)	2006-01-02
AR039256A1 (es)	2005-02-16
DK1500654T3 (da)	2006-06-06
US7056914B2 (en)	2006-06-06
TNSN04203A1 (en)	2007-03-12
UA79460C2 (en)	2007-06-25
WO2003084952A1 (en)	2003-10-16
PT1500654E (pt)	2006-06-30
JP2005529866A (ja)	2005-10-06
ES2258219T3 (es)	2006-08-16
WO2003084939A1 (es)	2003-10-16
US20040067941A1 (en)	2004-04-08
RU2004133041A (ru)	2005-09-10
DE60303440D1 (de)	2006-04-13
ATE489382T1 (de)	2010-12-15
ECSP045353A (es)	2005-01-28
ATE316966T1 (de)	2006-02-15
DE60303440T2 (de)	2006-10-26
AU2003222804A1 (en)	2003-10-20
BR0309083A (pt)	2005-04-19
KR20050008679A (ko)	2005-01-21
US7514429B2 (en)	2009-04-07
NZ536167A (en)	2006-06-30
CA2481701A1 (en)	2003-10-16
AU2003216934A1 (en)	2003-10-20
HRP20040919A2 (en)	2005-04-30
EP1500654B1 (en)	2006-02-01
MXPA04009889A (es)	2005-08-16
EP1500654A1 (en)	2005-01-26
US20040058920A1 (en)	2004-03-25
AR048567A1 (es)	2006-05-10
IS7491A (is)	2004-10-06
ES2193875A1 (es)	2003-11-01
ZA200408275B (en)	2006-04-26
CN1659164A (zh)	2005-08-24
EP1497285A1 (en)	2005-01-19
ES2356815T3 (es)	2011-04-13
HK1069820A1 (en)	2005-06-03
US20060128701A1 (en)	2006-06-15
DE60335094D1 (de)	2011-01-05

Publication	Publication Date	Title
IL164442A0 (en)	2005-12-18	Benzoxazinone-derived compounds, their preparationand use as medicaments
IL163711A0 (en)	2005-12-18	Macrocyclic compounds useful as pharmaceuticals
TWI341314B (en)	2011-05-01	New compounds
GB0307891D0 (en)	2003-05-14	Chemical compounds,compositions and uses
GB0323845D0 (en)	2003-11-12	Chemical compounds,compositions and uses
IL177933A0 (en)	2006-12-31	New compounds
IL166650A0 (en)	2006-01-15	New compounds
AU2003264018A8 (en)	2004-02-25	New compounds
GB0212321D0 (en)	2002-07-10	Catalyst composition
IL163894A0 (en)	2005-12-18	New compounds
EP1542699A4 (en)	2009-03-25	COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
IL175300A0 (en)	2006-09-05	Indirubin-type compounds, compositions, and methods for their use
IL175245A0 (en)	2006-09-05	Thiozolidinones, production and use thereof as medicaments
HUP0500871A3 (en)	2006-11-28	5-aryltetrazole compounds, compositions thereof and their use
EP1695761A4 (en)	2012-04-04	CATALYTIC COMPOSITION
GB0206861D0 (en)	2002-05-01	Medicaments
ZA200506744B (en)	2006-06-28	PyrazoloÄ1,5-AÜpyrimidine derivatives
GB0306418D0 (en)	2003-04-23	Catalyst composition
GB0211578D0 (en)	2002-06-26	Medicaments
HU0203976D0 (en)	2003-01-28	New compounds
GB0307695D0 (en)	2003-05-07	Compounds,compositions and processes
GB0314733D0 (en)	2003-07-30	Medicaments
GB0308968D0 (en)	2003-05-28	Medicaments
IL173004A0 (en)	2006-06-11	Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
HU0304095D0 (en)	2004-03-29	Novel, effective pharmaceutical compositions